Page last updated: 2024-08-24

irinotecan and Creutzfeldt-Jakob Syndrome

irinotecan has been researched along with Creutzfeldt-Jakob Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aoyama, T; Hamano, T; Hashimura, T; Kawai, J; Kimura, H; Uegaki, M	1

Reviews

1 review(s) available for irinotecan and Creutzfeldt-Jakob Syndrome

Article	Year
[Carboplatin plus irinotecan induced partial response in a patient with small cell carcinoma of the prostate; a case report]. Hinyokika kiyo. Acta urologica Japonica, 2014, Volume: 60, Issue:1 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Creutzfeldt-Jakob Syndrome; Fatal Outcome; Humans; Irinotecan; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Phosphopyruvate Hydratase; Prostate; Prostatic Neoplasms; Transurethral Resection of Prostate; Treatment Outcome	2014

Article

Year

[Carboplatin plus irinotecan induced partial response in a patient with small cell carcinoma of the prostate; a case report].

Hinyokika kiyo. Acta urologica Japonica, 2014, Volume: 60, Issue:1

Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Creutzfeldt-Jakob Syndrome; Fatal Outcome; Humans; Irinotecan; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Phosphopyruvate Hydratase; Prostate; Prostatic Neoplasms; Transurethral Resection of Prostate; Treatment Outcome

2014